AXDX has a patented device for the detection of drug resistant bacteria that has yet to hit the big hospitals. The delay has affected AXDX's stock price.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
